EU approves J&J purchase of Actelion subject to conditions

BRUSSELS (Reuters) - EU antitrust regulators approved on Friday Johnson & Johnson's planned purchase of Actelion Pharmaceutical subject to conditions intended to ensure clinical development of insomnia drugs were unaffected.

EU approves J&J purchase of Actelion subject to conditions
Read More


Bagikan Berita Ini